Albert Qin

13PUBLICATIONS
13CO-AUTHORS
Molecular targetsGene and molecular therapyMedical biotechnology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 02, 2026
Beyond Oncogenes: Selectively Targeting Whole-Tumor Cell Growth Regulation.

Albert Qin

|Oct 31, 2025
Long-term efficacy and safety of ropeginterferon alfa-2b under its HIDAT regimen for the treatment of polycythemia vera.

Shanshan Suo, Rongfeng Fu, Albert Qin

|May 02, 2025
Population Pharmacokinetics-Pharmacodynamics and Exposure-Response of Ropeginterferon Alfa-2b in Chinese and Japanese Patients With Polycythemia Vera.

Albert Qin, Kazuya Shimoda, Shanshan Suo

|Jan 13, 2025
The higher initial dose and accelerated titration regimen of ropeginterferon as a treatment option for certain patients with polycythaemia vera.

Albert Qin, Lei Zhang, Jie Jin

|Oct 27, 2024
Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b.

Shanshan Suo, Rong Feng Fu, Albert Qin

|Sep 14, 2024
A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer.

Xu Xu, Shih-Long Yan, Yi-Te Yo

Pageof 3

Frequent Collaborators

2 joint publications

Jie Jin

2 joint publications

Lei Zhang

2 joint publications

Minghui Duan

2 joint publications

Sujiang Zhang